And if you have an iPhone or iPad, go download my Webby Award-winning app! With over 100 Whole30-approved recipes, interactive guides, a customizable shopping list, fully-emailable recipes, and a 30-day Whole30 meal plan, this app is an invaluable tool for Paleo foodies and culinary newbies alike. There’s even a dedicated Whole30 recipe category in the app!
A study published in the Journal of Strength and Conditioning Research entitled "Crossfit-based high intensity power training improves maximal aerobic fitness and body composition" followed 54 participants for 10 weeks of CrossFit training. The study said that "...a notable percentage of our subjects (16%) did not complete the training program and return for follow-up testing." The authors said "This may call into question the risk-benefit ratio for such extreme training programs..." In 2014, CrossFit, Inc. filed a lawsuit against the National Strength and Conditioning Association for publishing this study, alleging that the data were false and were "intended to scare participants away from CrossFit." The NSCA denies CrossFit, Inc.'s allegations but has issued an erratum acknowledging that the injury data were incorrect. In September 2016, the District Court ruled in favor of CrossFit Inc.'s claims that the injury data were found to be false, but not that the NSCA was commercially motivated or that the publishing of the study was defamatory as the NSCA no longer stood behind the study. In February 2017, CrossFit filed for sanctions against the NSCA after one of the NSCA's witnesses admitted to falsifying statements during deposition. In May 2017, the Court issued 17 issues sanctions against the NSCA, writing that the organization did have a commercial motive to falsify the data, had published the false data knowingly to disparage CrossFit, and had misled the public with their erratum. CrossFit was awarded $74,000 in legal fees and allowed to continue investigating the NSCA. If the neutral-party analysis of the NSCA servers turns up any further misconduct, CrossFit may file an amended complaint for further sanctioning and compensation for lost revenue.
The Art and Science of Low Carbohydrate Living: An Expert Guide to Making the Life-Saving Benefits of Carbohydrate Restriction Sustainable and Enjoyable by Stephen D. Phinney and Jeff S. Volek synthesizes the science into one readable source. The book is excellent for general low-carb high-fat moderate protein diets. While they begin with the idea that we should eat like a caveman, they do not follow the conclusion to its logical end and have us avoid the classes of foods our ancestors would have found unrecognizable. They avoid the metobolic syndrome, but not the autoimmune diseases. They mention that monosaturates should be favored, though they are not emphasized in the menu example. The book's daily menu examples also all include dairy in one form or another. No tips are given tips for those who do not do dairy. Published May 19, 2011. The Amazon reviews average to 4+.
This is one of the best cookbooks I have ever purchased and I have nearly 100! Most cookbooks I might find 3-4 good recipes out of dozens. Out of the 150 recipes in this book there are maybe 10 that I wouldn't make but 140 I would! The pictures are great! The recipes are delicious. I don't really even feel like I'm eating healthy because the food just tastes so great!
Good Calories, Bad Calories: Fats, Carbs, and the Controversial Science of Diet and Health by Gary Taubes expounds on his 2002 article in the NY Times (What if It's All Been a Big Fat Lie?) and then in Science Magazine (see below). He shows how public health data has been misinterpreted to mark dietary fat and cholesterol as the primary causes of coronary heart disease. Deeper examination, he says, shows that heart disease and other diseases of civilization appear to result from increased consumption of refined carbohydrates: sugar, white flour and white rice. Or in other words, without using the word Paleolithic, he justifies the paleo diet. Here is an excellent chapter by chapter summary of the book [archive.org].
Following seven years in Carson, the Games moved to the Alliant Energy Center in Madison, Wisconsin, in 2017. The next year, the qualifying Regionals were once again realigned due to increased competitiveness and popularity outside of Canada and the US. In 2018, there were nine Regionals hosted among 18 redefined regions with Europe increasing to three regions, Central America split from South America, while eliminating the Northern and Southern California regions.
Generally speaking, dieters are advised to eat between 20-30 grams of carbohydrates per day in order to maintain ketosis. To put this into perspective, a quarter cup of steel cut oats has 29 grams of carbs and a banana has roughly 27 grams of carbs. So if you have a few bites of oatmeal or a small piece of fruit, whoops! That's your carb intake for the day.
A great question to ask is “Does the Paleo diet work?” Here we have a head to head comparison between the Paleo diet and Mediterranean diet in insulin resistant Type 2 Diabetics. The results? The Paleo diet group REVERSED the signs and symptoms of insulin resistant, Type 2 diabetes. The Mediterranean diet showed little if any improvements. It is worth noting that the Mediterranean diet is generally held up by our government as “the diet to emulate” despite better alternatives. You can find an abstract and the complete paper here.
The China Study is frequently cited when criticizing the Paleo Diet – focusing on a vegetarian diet and consuming rice is healthier than the Paleo Diet. I respectfully disagree with the conclusions drawn from that book but that’s awesome if you want to go plant-based! , and will leave you to make your own conclusions based on your own self-experimentation.
The WHO trial (so named because the international team of principal investigators contained World Health Organization members) tested the potential of clofibrate, a “pre-statin” cholesterol-lowering agent, to reduce heart attack morbidity and mortality. The investigators ultimately concluded that clofibrate "cannot be recommended as a lipid-lowering drug for community-wide primary prevention of ischaemic heart disease.” Nevertheless, clofibrate remained in use until 2002, when it was pulled for increasing cancer rates. In their review of studies such as the WHO trial, Uffe Ravnskov and David Diamond observe, “Despite the largely disappointing findings from 50 years of cholesterol lower[ing] trials, the indictment and conviction of cholesterol as the causal agent in CVD [cardiovascular disease] has stood the test of time. … [Yet] the grand effort to reduce cholesterol as a strategy to improve health has failed.”